三体

Dharmendra's Last Film Ikkis' Release Date Pushed Amid Dhurandhar Craze, Here's The New Release Date_我的网站

杨光的快乐生活

一 | Ikkis, the war drama that will see Amitabh Bachchan's grandson Agastya Nanda's make his theatrical debut will not be released on December 25, as announced before. The release date of the Sriram Raghavan directorial has not been pushed to 2026. The social media handle of Maddock Films announced this and wrote, "This new year, gift yourself courage. Final #Ikkis trailer drops this weekend in theatres. A new chapter unfolds in legendary director Sriram Raghvan’s first war film. The true story of India’s youngest Param Vir Chakra Awardee, Second Lt. Arun Khetarpal. Some heroes die young. #IkkisTrailerOutNow - Link in bio. Experience courage in cinemas. #Ikkis releasing on 1st January 2026." The film will now be released on January 1, 2026. Take a look at the post: View this post on Instagram A post shared by Maddock Films (@maddockfilms) With this new development, producer Dinesh Vijan has once again employed his proven strategy of choosing clarity over clashes, a move that earlier worked in favour of Hindi Medium and Chhaava. Ikkis marks Sriram Raghavan's first war film and brings to life the extraordinary true story of Second Lieutenant Arun Khetarpal, India’s youngest Param Vir Chakra awardee. Besides Agastya, Ikkis will also see the debut of Akshay Kumar's niece Simar Bhatia. What makes Ikkis even more special and emotional is that it will be Dharmendra's posthumous release. This is the last film the actor shot for before passing away in November this year. He plays Agastya's on-screen father, Brigadier M. L. Khetarpal. Pooja Ladha Surti, the film's editor and co-writer, has discussed how Raghavan and Vijan plan to pay tribute to Dharmendra. In a conversation with SCREEN, Pooja shared, “Yes, I am sure Sriram and Dinoo (Dinesh Vijan, producer) will do that. His final performance will speak more than any tribute from us, I feel.” Also Read: Photos: Dharmendra’s Heartfelt BTS Moments From The Sets of Ikkis。 8 月 25 日消息，万泰生物今日公告，公司实际控制人钟睒睒于 2026 年 8 月 25 日与福建省翔安创新实验室科技发展基金会签署协议，拟向该基金会无偿捐赠其直接持有的公司 3300 万股无限售条件流通股，占公司目前总股本的 2.61%。本次捐赠旨在支持公共健康与生物医学的前沿研究探索。

二 | 注意到，以万泰生物 8 月 25 日收盘价 28.1 元 / 股测算，本次捐赠的 3300 万股对应市值约 9.27 亿元。福建省翔安创新实验室科技发展基金会承诺，在受让捐赠股份后 6 个月内不减持，且未来减持时将与钟睒睒合并计算减持额度。万泰生物公告显示，捐赠实施前，钟睒睒直接持有公司 17.71% 股份，并通过控股股东养生堂有限公司持有 55.82% 股份，合计持股 73.53%。捐赠完成后，其直接持股比例降至 15.10%，合计持股比例降至 70.92%（总股本数据截至公告披露日）。本次捐赠不会导致公司控制权发生变化。